000			04644cam a2200457Ii 4500
988			_aSpringer_Medicine_2017
999			_c94968 _d94968 _x1
001			94968
003			ES-MaUEC
005			20230102112640.0
006			m o d
007			cr cnu---unuuu
008			161202s2016 sz ob 001 0 eng d
020			_a331942307X _q(electronic bk.)
020			_a9783319423074 _q(electronic bk.)
020			_z3319423053
020			_z9783319423050
035			_a(OCoLC)964698652 _z(OCoLC)965140844
040			_aN$T _cN$T _dN$T _dYDX _dIDEBK _dEBLCP _dGW5XE _dUAB _dIOG _dMERER _dESU _dZ5A _dOCLCQ _dJBG _dIAD _dICW _dICN _dOTZ _dOCLCQ _dU3W _dES-MaUEC _bspa
050		4	_aRM666.H33 _b2017 EB
245	0	0	_aEvidence-based herbal and nutritional treatments for anxiety in psychiatric disorders _cDavid Camfield, Erica McIntyre, Jerome Sarris, editors.
264		1	_aCham _bSpringer _c2016
300			_a1 recurso en línea
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
500			_aSpringerLink
504			_aIncluye referencias bibliográficas e índice
505	0		_aForeword; References; Acknowledgements; Contents; 1: The Need for€Evidence-Based Herbal and€Nutritional Anxiety Treatments in€Psychiatry; 1.1 The Experience of€Anxiety; 1.2 Limitations of€Current Treatment Approaches; 1.3 Nutritional and€Herbal Treatments for€Anxiety; 1.4 Varied Mechanisms of€Anxiolytic Actions; 1.5 Challenges for€an€Emerging Herbal and€Nutraceutical Industry; 1.6 The Scope of€This Book; References; Part I: Clinical Evidence in Support of Herbal and Nutritional Treatments for Anxiety; 2: Herbal Anxiolytics with€Sedative Actions; 2.1 Introduction.
505	8		_a2.2 Kava (Piper methysticum)2.2.1 Overview; 2.2.2 Mechanisms of€Action; 2.2.2.1 Constituents; 2.2.3 Evidence of€Efficacy; 2.2.3.1 Anxiety; 2.2.3.2 Mental Function; 2.3 Passionflower (Passiflora incarnata); 2.3.1 Overview; 2.3.2 Mechanisms of€Action; 2.3.2.1 In Vivo Studies; 2.3.3 Evidence of€Efficacy; 2.3.3.1 Clinical Studies; 2.4 Chamomile (Matricaria recutita); 2.4.1 Overview; 2.4.2 Mechanisms of€Action; 2.4.3 Evidence of€Efficacy; 2.4.3.1 Clinical Studies; 2.5 Galphimia (Galphimia glauca); 2.5.1 Overview; 2.5.2 Mechanisms of€Action; 2.5.3 Evidence of€Efficacy.
505	8		_a2.5.3.1 Preclinical2.5.3.2 Clinical; 2.6 Skullcap (Scutellaria lateriflora); 2.6.1 Overview; 2.6.2 Mechanisms of€Action; 2.7 Evidence of€Efficacy; 2.7.1 Preclinical; 2.7.2 Clinical; 2.8 Valerian (Valeriana spp.); 2.8.1 Overview; 2.8.1.1 Mechanisms of€Action; 2.8.2 Evidence of€Efficacy; 2.8.3 Preclinical; 2.8.3.1 Clinical; 2.8.4 Clinical Considerations; References; 3: Adaptogens; 3.1 Introduction; 3.2 Ashwagandha (Withania somnifera); 3.2.1 Overview; 3.2.1.1 Mechanisms of€Action; 3.2.2 Evidence of€Efficacy; 3.2.2.1 Preclinical Studies; 3.2.2.2 Clinical Studies.
505	8		_a3.2.2.3 Safety3.3 Roseroot (Rhodiola rosea); 3.3.1 Overview; 3.3.1.1 Mechanism of€Action; 3.3.1.2 Preclinical Studies; 3.3.1.3 Clinical Studies; 3.3.1.4 Safety; 3.4 Gotu Kola (Centella asiatica); 3.4.1 Overview; 3.4.1.1 Mechanism of€Action; 3.4.1.2 Preclinical Studies; 3.4.1.3 Clinical Studies; 3.4.1.4 Safety; 3.5 Siberian Ginseng (Eleutherococcus senticosus); 3.5.1 Mechanism of€Action; 3.5.2 Preclinical Studies; 3.5.3 Clinical Studies; 3.6 Schisandra (Schisandra chinensis); 3.6.1 Mechanism of€Action; 3.6.2 Preclinical Studies; 3.6.3 Clinical Studies; 3.6.4 Safety.
505	8		_a3.7 Combination Preparations3.7.1 Clinical Considerations; References; 4: Cognitive Anxiolytics; 4.1 Introduction; 4.2 Brahmi (Bacopa monnieri); 4.2.1 Overview; 4.2.2 Mechanisms of€Action; 4.2.3 Evidence of€Efficacy; 4.2.3.1 Preclinical; 4.2.3.2 Acute Clinical Studies; 4.2.3.3 Chronic Clinical Studies; 4.2.4 Conclusion; 4.3 Ginkgo (Ginkgo biloba); 4.3.1 Overview; 4.3.2 Mechanisms of€Action; 4.3.2.1 Constituents; 4.3.3 Evidence of€Efficacy; 4.3.3.1 Preclinical; 4.3.3.2 Clinical; 4.3.4 Conclusion; 4.4 Lemon Balm (Melissa officinalis); 4.4.1 Overview.
588	0		_aOnline resource; title from PDF title page (EBSCO, viewed December 6, 2016).
650		7	_2embne _9157984 _aFitoterapia
700	1		_aCamfield, David, _eeditor literario
700	1		_aMcIntyre, Erica, _eeditor literario
700	1		_aSarris, Jerome, _eeditor literario
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-42307-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2018 _dz _e- _zSI